Alopecia – Drugs In Development, 2023
Powered by
Unlock hidden opportunities in the Pharmaceuticals industry
Global Markets Direct’s, ‘Alopecia – Drugs In Development, 2023’, provides an overview of the Alopecia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note:
*Certain sections in the report may be removed or altered based on the availability and relevance of data.
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase
* Global Markets Direct, is a research brand owned and operated by GlobalData.
Scope
- The report provides a snapshot of the global therapeutic landscape of Alopecia
- The report reviews pipeline therapeutics for Alopecia by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Alopecia therapeutics and enlists all their major and minor projects
- The report assesses Alopecia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Alopecia
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Alopecia
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Alopecia pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Key Players
AbbVie IncAccro Bioscience Suzhou Co Ltd
Addpharma Inc
Akaal Pharma Pty Ltd
Aldena Therapeutics Inc
Almirall SA
Amplifica Holdings Group Inc
Aneira Pharma Inc
Anhorn Medicines Co Ltd
Annji Pharmaceutical Co Ltd
AnTolRx Inc
Arcutis Biotherapeutics Inc
Aslan Pharmaceuticals Ltd
Augusta University
Biolab Sanus Farmaceutica Ltda
BiologicsMD Inc
BirchBioMed Inc
BPGbio Inc
Bristol-Myers Squibb Co
CAGE Biosciences Inc
Caregen Co Ltd
Celiaz Co Ltd
Chengdu Zenitar Biomedical Technology Co Ltd
Chong Kun Dang Pharmaceutical Corp.
CK Regeon Inc
Concert Pharmaceuticals Inc
Cosmo Pharmaceuticals NV
Cutia Therapeutics (HK) Ltd
Dermaliq Therapeutics Inc
dNovo Inc
E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd
Eirion Therapeutics Inc
EMS SA
Epibiotech Co Ltd
Equillium Inc
Exicure Inc
Follica Inc
Follicle Pharma Ltd
Forte Biosciences Inc
Gurus BioPharm Inc
Hangzhou Metai Pharmaceutical Technology Co Ltd
Haplnscience Inc
HCell Inc
HCW Biologics Inc
Hope Medicine Inc
Horizon Therapeutics Plc
Huons Global Co Ltd
Inmagene Biopharmaceuticals Ltd
Innovo Therapeutics Co Ltd
Inventage Lab Inc
JN Biosciences LLC
Johns Hopkins University
JW Pharmaceutical Corp
Kanpecia Biotech LLC
Kintor Pharmaceutical Ltd
Kuhnil Pharmaceutical Co Ltd
Leo Pharma AS
LG Chem Ltd
Longwood Biopharmaceuticals Co Ltd
Mallia Therapeutics GmbH
Maruho Co Ltd
Maxinovel Pharmaceuticals
Medispan
Merz Pharma GmbH & Co KgaA
Mirae Cell Bio Co Ltd
MPC Therapeutics
Nanjing Minova Pharmaceutical Technology Co Ltd
Nektar Therapeutics
Nepsone ehf
Nextgen Bioscience
OliX Pharmaceuticals Inc
Omega Therapeutics Inc
OnQuality Pharmaceuticals LLC
Ornovi Inc
Pelage Pharmaceuticals Inc
Pfizer Inc
Phio Pharmaceuticals Corp
ProTransit Nanotherapy LLC
Q32 Bio Inc
Regeneron Pharmaceuticals Inc
Reistone Biopharma Co Ltd
RiverTown Therapeutics Inc
Safety Shot Inc
Samson Clinical Pty Ltd
Serpin Pharma LLC
Shenzhen 01 Life Technology Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Ship of Theseus LLC
Sichuan Huiyu Pharmaceutical Co Ltd
Sisaf Ltd
Soterios Ltd
Stemson Therapeutics Corp
Sun Pharma Advanced Research Company Ltd
Sun Pharmaceutical Industries Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Technoderma Medicines Inc
Throne Biotechnologies Inc
Tigo GmbH
Triple Hair Inc
TS Cell Bio Co Ltd
Turn Biotechnologies Inc
University of California Los Angeles
VasoDynamics Ltd
VeraDermics Inc
YIRUI Pharmaceutical Technology Co Ltd
Yooyoung Pharm Co Ltd
Zura Bio Ltd